The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
Interactive tool for asthma patients to help self-assessment
September 27, 2023
Do you need a Patient Information Leaflet for your medication?
September 26, 2023
Understanding Sepsis: A Patient’s Guide
September 26, 2023
Martha’s Rule: A Lifeline for Patients and Families in the NHS
September 6, 2023
NHS Complaint Procedures
September 4, 2023
Accessing GP Services: A Detailed Overview
August 31, 2023
Unvalidated Laboratory Testing
August 2, 2023
Osteoporosis (Thinning bones)
August 1, 2023
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video